A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis

Condition:   Colitis, Ulcerative Interventions:   Drug: GLPG3970;   Drug: Placebo Sponsor:   Galapagos NV Recruiting

Source: ClinicalTrials.gov - October 7, 2020 Category: Research Source Type: clinical trials